Exosome: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Exosome== | ==Exosome== | ||
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | ||
This is a default text for your page '''Exosome'''. Click above on '''edit this page''' to modify. Be careful with the < and > signs. | This is a default text for your page '''Exosome'''. Click above on '''edit this page''' to modify. Be careful with the < and > signs. | ||
| Line 10: | Line 9: | ||
'''Autoimmunity''' | '''Autoimmunity''' | ||
The exosome complex is the target of autoantibodies in | The exosome complex is the target of autoantibodies, which are known to be found in people that suffer from various autoimmune diseases (especially PM/Scl overlap syndrome). In the autoimune diseases, antibodies are mainly directed against two of the proteins of the complex, called PM/Scl-100 and PM/Scl-75. | ||
'''Cancer treatment''' | '''Cancer treatment''' | ||
The | The Exosome is found to be inhibited by a cancer chemotherapy drug, which called antimetabolite fluorouracil. This drug is one of the most successful drugs for treating solid tumors. | ||
== Relevance == | == Relevance == | ||
Revision as of 10:59, 21 November 2014
Exosome
| ||||||||||||